Blog

If you haven’t heard of remdesivir, an antiviral drug, you will soon. Remdesivir is one of the most promising treatments for COVID-19 that is undergoing trial testing. In fact, shares of the drug’s maker, Gilead Sciences (NASDAQ: GILD), surged close to 10% on 17th April when initial...